MITO logo

Stealth BioTherapeutics (MITO) Cash From Operations

MITO Annual CFO

-$44.97 M
+$8.57 M+16.00%

31 December 2021

MITO Cash From Operations Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

MITO Quarterly CFO

N/A

31 March 2022

MITO Quarterly CFO Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

MITO TTM CFO

N/A

31 March 2022

MITO TTM CFO Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

MITO Cash From Operations Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+16.0%--
3 y3 years+37.6%--
5 y5 years+35.6%--

MITO Cash From Operations High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year
5 y5-year
alltimeall timeat high

Stealth BioTherapeutics Cash From Operations History

DateAnnualQuarterlyTTM
Dec 2021
-$44.97 M(-16.0%)
-
-
June 2021
-
-$23.28 M(-46.9%)
-$67.10 M(-12.5%)
Dec 2020
-$53.54 M(+11.6%)
-
-
Sept 2020
-
-$43.82 M(+33.2%)
-$76.72 M(-11.0%)
June 2020
-
-$32.90 M
-$86.21 M
DateAnnualQuarterlyTTM
Dec 2019
-$47.98 M(-33.4%)
-
-
Sept 2019
-
-$53.31 M(+4.7%)
-$53.31 M(+4.7%)
Dec 2018
-$72.08 M(+3.2%)
-
-
Sept 2018
-
-$50.91 M
-$50.91 M
Dec 2017
-$69.83 M(+29.3%)
-
-
Dec 2016
-$54.02 M
-
-

FAQ

  • What is Stealth BioTherapeutics annual cash flow from operations?
  • What is the all time high annual CFO for Stealth BioTherapeutics?
  • What is Stealth BioTherapeutics annual CFO year-on-year change?
  • What is the all time high quarterly CFO for Stealth BioTherapeutics?
  • What is the all time high TTM CFO for Stealth BioTherapeutics?

What is Stealth BioTherapeutics annual cash flow from operations?

The current annual CFO of MITO is -$44.97 M

What is the all time high annual CFO for Stealth BioTherapeutics?

Stealth BioTherapeutics all-time high annual cash flow from operations is -$44.97 M

What is Stealth BioTherapeutics annual CFO year-on-year change?

Over the past year, MITO annual cash flow from operations has changed by +$8.57 M (+16.00%)

What is the all time high quarterly CFO for Stealth BioTherapeutics?

Stealth BioTherapeutics all-time high quarterly cash flow from operations is -$23.28 M

What is the all time high TTM CFO for Stealth BioTherapeutics?

Stealth BioTherapeutics all-time high TTM cash flow from operations is -$50.91 M